Drugs / GREZIPRUBART
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 15 trials | ||||||
| Phase 1 | NCT05702983 | Jan → Apr 2023 | anti-neutrophil cytoplasmic antibody-associated vasculitis | Staidson (Beijing) Biopharmaceuticals Co., Ltd | Completed | No outcome recorded |
| Phase 1 | NCT05559125 | Nov 2022 → Mar 2024 | — | Staidson (Beijing) Biopharmaceuticals Co., Ltd | Terminated | No outcome recorded |
| Phase 1 | NCT05497635 | Oct 2022 → Apr 2023 | — | Staidson (Beijing) Biopharmaceuticals Co., Ltd | Completed | No outcome recorded |
| Phase 1 | NCT05166837 | Jan 2022 → Jan 2023 | — | Staidson (Beijing) Biopharmaceuticals Co., Ltd | Completed | No outcome recorded |
| Phase 1 | NCT05032144 | Sep 2021 → Mar 2022 | — | Staidson (Beijing) Biopharmaceuticals Co., Ltd | Completed | No outcome recorded |
| Phase 1/21 trial · 1 missed | ||||||
| Phase 1/2 | NCT06038916 | Dec 2023 → Mar 2025 | adult acute respiratory distress syndrome | Staidson (Beijing) Biopharmaceuticals Co., Ltd | Completed | Missed primary |
| Phase 31 trial | ||||||
| Phase 3 | NCT07208591 | Oct 2025 → Jul 2026 overdue | acute respiratory distress syndrome | Staidson (Beijing) Biopharmaceuticals Co., Ltd | Recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GREZIPRUBART | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068253 ↗ |
| Known as | STSA-1002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05702983 ↗ |
| Action | Inhibit | “STSA-1002 was a high-affinity, selective anti-human C5a monoclonal antibody blocking C5a-mediated reactive oxygen species (ROS) production.” PMID 42394970 ↗ Jun 2026 |
| Modality | Monoclonal antibody | “STSA-1002 is a fully human monoclonal antibody” PMID 42394970 ↗ Jun 2026 |
| Route | Intravenous | “Intravenous injection” NCT05032144 ↗ |